COVID is an international, peer-reviewed, open access journal published quarterly online by MDPI.
  • Open Access—Free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 14.4 days after submission; acceptance to publication is undertaken in 5.5 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • COVID is a companion journal of Viruses.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Viruses, Biomedicines, Pharmaceuticals, Pharmaceutics, COVID
Broad-Spectrum Antiviral Agents Editors-in-Chief: Cheng-Wen Lin, Szu-Hao Kung
Deadline: 31 December 2021
Topic in COVID, IJMS, Microorganisms, Viruses
Liquid-Liquid Phase Separation Editors-in-Chief: Maria João Amorim, Yohei Yamauchi
Deadline: 31 March 2022
Special Issue in COVID
SARS-CoV Spike Glycoprotein: Structure and Function Guest Editors: Konstantinos Poulas, Konstantinos Farsalinos, George Lagoumintzis
Deadline: 30 November 2021
Special Issue in COVID
Molecular Modeling Approaches and Therapeutic Repositioning of Drugs against COVID-19 Guest Editor: Jorddy Cruz
Deadline: 31 December 2021
Back to TopTop